Blood Simpling
Reference number | |
Coordinator | Blood Simpling AB |
Funding from Vinnova | SEK 300 000 |
Project duration | October 2023 - May 2024 |
Status | Completed |
Venture | Innovative Startups |
Call | Innovative Impact Startups autumn 2023 |
Important results from the project
The project goals have been achieved through testing and adjustments of the prototype as well as verification and validation. We have also deepened our understanding of customer benefits, market needs, and purchasing processes, which has strengthened our market strategy and the product´s potential.
Expected long term effects
The result of the project is a prototype where key steps have been developed, verified, and validated. Expected effects include increased customer benefits, better market adaptation, and a stronger market position. The project has also contributed to a deeper understanding of market needs and purchasing processes.
Approach and implementation
The structure and execution of the project involved a systematic development process focused on testing, verification, and validation of the prototype. Regular feedback from users and experts allowed us to adjust and improve the design. Additionally, market analyses were conducted to ensure the product meets customer needs and requirements, strengthening our development strategy.